Helix BioPharma Corp. (HBP) — Net Asset Quality Index
Helix BioPharma Corp. (HBP) has a Net Asset Quality Index of 84.3% as of October 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$19.07 Million minus total liabilities of CA$3.00 Million yields net assets of CA$16.07 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore HBP current and non-current assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Helix BioPharma Corp. Net Asset Quality Index Over Time (2007–2025)
This chart shows how Helix BioPharma Corp.'s Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of October 2025, the index stands at 84.3%, representing net assets of CA$16.07 Million against total assets of CA$19.07 Million CAD. See working capital position of Helix BioPharma Corp. to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Helix BioPharma Corp. (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for Helix BioPharma Corp. from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Helix BioPharma Corp. worth.
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.9% | CA$15.59 Million | CA$18.80 Million | CA$3.22 Million | ▲ +88.9 pp |
| 2024 | -6.0% | CA$-90.00K | CA$1.49 Million | CA$1.58 Million | ▲ +76.0 pp |
| 2023 | -82.0% | CA$-844.00K | CA$1.03 Million | CA$1.87 Million | ▼ -90.6 pp |
| 2022 | 8.6% | CA$319.00K | CA$3.73 Million | CA$3.41 Million | ▲ +42.8 pp |
| 2021 | -34.3% | CA$-1.39 Million | CA$4.07 Million | CA$5.46 Million | ▼ -95.0 pp |
| 2020 | 60.8% | CA$2.98 Million | CA$4.91 Million | CA$1.93 Million | ▲ +409.8 pp |
| 2019 | -349.0% | CA$-3.28 Million | CA$940.00K | CA$4.22 Million | ▼ -215.9 pp |
| 2018 | -133.1% | CA$-1.53 Million | CA$1.15 Million | CA$2.67 Million | ▼ -132.4 pp |
| 2017 | -0.8% | CA$-17.00K | CA$2.19 Million | CA$2.20 Million | ▼ -71.6 pp |
| 2016 | 70.8% | CA$3.16 Million | CA$4.47 Million | CA$1.30 Million | ▼ -16.8 pp |
| 2015 | 87.6% | CA$6.83 Million | CA$7.80 Million | CA$969.00K | ▲ +0.8 pp |
| 2014 | 86.7% | CA$6.81 Million | CA$7.85 Million | CA$1.04 Million | ▲ +2.9 pp |
| 2013 | 83.8% | CA$4.92 Million | CA$5.87 Million | CA$948.00K | ▲ +2.1 pp |
| 2012 | 81.7% | CA$6.22 Million | CA$7.62 Million | CA$1.39 Million | ▼ -9.0 pp |
| 2011 | 90.7% | CA$22.11 Million | CA$24.37 Million | CA$2.26 Million | ▲ +3.7 pp |
| 2010 | 87.0% | CA$15.76 Million | CA$18.11 Million | CA$2.35 Million | ▼ -1.3 pp |
| 2009 | 88.3% | CA$17.06 Million | CA$19.32 Million | CA$2.26 Million | ▼ -6.4 pp |
| 2008 | 94.7% | CA$20.52 Million | CA$21.67 Million | CA$1.14 Million | ▲ +5.5 pp |
| 2007 | 89.2% | CA$12.73 Million | CA$14.27 Million | CA$1.54 Million | — |